Trim to underweight by 25-40%, wait for either a confirmed close above 167.81 or a flush below 147.61 before committing additional capital; do not initiate new shorts in the $160-163 zone; define risk at $170.

• Forward EPS consensus of $10.26 may need revision but the stock has already repriced from $221 to $162, with most earnings revisions likely already discounted
• A PEG of 1.0 with 33.75% ROE, net debt to EBITDA under 1x, and 2.19% dividend yield is a fair value signal, not a sell signal
• Q2'26 FCF was depressed by $1.65 billion working capital headwind from inventory build—the $10 billion TTM FCF is more representative than a single depressed quarter
• The $170 stop is barely more than one ATR ($8.99) in a stock that can move $7-10 in a single session on news
• MACD histogram positive for 4 sessions, RSI divergence is real, Bollinger Band squeeze is real, ATR contraction is real, and 7/31 low at 147.61 held
• The 9.7M share bounce versus 9.2M share sell-off is essentially two-sided action, not distribution
• QCOM at 15.8x forward earnings with 2.19% dividend is a value multiple, not a growth multiple—higher-for-longer rates argument doesn't apply the same way
• Polymarket no-cut odds of 86% can shift dramatically on any inflation print or Fed communication
• $9 billion in buybacks provides structural bid support at current levels
• The trader's own framework (cautious trim) aligns with the conservative position—the aggressive analyst is trying to talk them out of their own disciplined approach

→ vs aggressive: The 'high-conviction, asymmetric' framing is actually a knife-edge setup where the next 10-15% move is a coin flip between washout reversal and continuation

→ vs aggressive: The denominator problem argument on PEG ratio is circular—the market has already repriced the stock from $221 to $162, and most earnings revisions are already discounted

→ vs aggressive: The FCF collapse argument ignores the $1.65 billion working capital headwind in Q2'26—if inventory clears, FCF normalizes, making $10 billion TTM more meaningful than a single depressed quarter

→ vs aggressive: A stop at $170 is barely one ATR ($8.99) above entry in a stock that can move $7-10 in a single session—this guarantees getting stopped out by normal volatility before any thesis plays out

→ vs aggressive: The aggressive analyst dismisses technical signals (MACD, RSI divergence, Bollinger squeeze, 147.61 support) as 'noise' but then engages in survivorship bias by only remembering failed signals, not ones that marked major lows

→ vs aggressive: The volume analysis showing 9.7M shares up versus 9.2M shares down is two-sided action, not distribution—calling it distribution is reading the chart with bias

→ vs aggressive: The macro thesis requires rates to stay exactly as hostile as they are now—a fragile foundation given how quickly Polymarket odds and oil prices can shift on de-escalation headlines

SELL (trim to 25-40% underweight with refined execution)

• The trader's SELL decision to trim to underweight is the right directional call; bearish fundamental case is intact, technical structure is damaged, macro backdrop is hostile
• Do not trim 25-40% in a single session at the open—scale over 3-5 sessions with limit orders at 162, 160, and 158 to reduce implementation cost
• Stop at $170 is too tight for a 1.66 beta name with $8.99 ATR—widen to $173-175 or restructure as layered position with 50% no-stop, 25% add at $153, 25% held for breakdown
• QCOM's 1.66 beta means a 5% underweight behaves like 8.3% position on beta-adjusted basis—consider 3-5% underweight if portfolio has other semiconductor or rate-sensitive exposure
• Express underweight via paired trade (long MU/MRVL vs short QCOM) or put spreads to hedge binary macro risks including Hormuz situation and Fed cut probabilities
• Re-entry framework requires volume confirmation—a close above 168 on 12-15M shares is materially different than on 6M shares; flush below 147.61 must be closing-basis with successful retest
• Q3 earnings call was just seven days ago and fair value cuts are still in motion; cannot claim repricing is complete when fundamental inputs are still being revised

→ vs aggressive: The $162 entry point with $10B TTM FCF and 33.75% ROE is not a falling knife—it has already fallen. Asymmetry claimed is anchored to a price point that no longer exists

→ vs aggressive: Cannot simultaneously argue consensus is wrong on EPS and that trade is asymmetric to downside—if consensus is wrong, floor is also priced at current levels

→ vs aggressive: Stop at $170 leaves less than one ATR of risk ($8.99 ATR, $9 one-standard-deviation move) in a 1.66 beta name with binary macro setup—this is a coupon for being wrong on a single volatile session

→ vs aggressive: The 8/10 $7 intraday range (162.08-168.87) represents indecision, not selloff conviction—reading one candle as a thesis misapplies failed 200 SMA retest signal

→ vs aggressive: Q2'26 FCF collapsed from $4.4B to $495M largely due to $1.65B working capital headwind—the underlying driver is one-time, not structural deterioration

→ vs conservative: Market repricing is not complete just because stock dropped 38% from highs—Simply Wall St. fair value cut to $196 was last week, Q3 earnings call was seven days ago, FCF trajectory still in motion

→ vs conservative: Constructive technical signals (MACD positive 4 sessions, RSI divergence single comparison, Bollinger squeeze) are early data points of potential basing pattern, not confirmation of basing

→ vs conservative: Volume analysis conclusion that 'neither side is dominant' is defensive reading—bounces unable to push above 200 SMA despite momentum signals shows sellers still control higher levels

→ vs conservative: 15.8x forward multiple on consensus earnings still being marked down is not a floor—it is a transitional price as AI/auto optionality gets priced out